[1] |
Li B, Yang Z, Li Y, et al.Exploration beyond osteoarthritis:the association and mechanism of its related comorbidities[J/OL].Front Endocrinol, 2024, 15: 1352671.DOI:10.3389/fendo.2024.1352671.
|
[2] |
De Roover A, Escribano-Núñez A, Monteagudo S, et al.Fundamentals of osteoarthritis: inflammatory mediators in osteoarthritis[J].Osteoarthritis Cartilage, 2023, 31( 10 ): 1303-1311.
|
[3] |
Siddiq MAB, Oo WM, Hunter DJ.New therapeutic strategies in osteoarthritis[J/OL].Joint Bone Spine, 2024, 91( 6 ): 105739.DOI:10.1016/j.jbspin.2024.105739.
|
[4] |
Lavrador P, Esteves MR, Gaspar VM, et al.Stimuli-responsive nanocomposite hydrogels for biomedical applications[J/OL].Adv Funct Materials, 2021, 31( 8 ): 2005941.DOI:10.1002/adfm.202005941.
|
[5] |
Chen X, Lei S, Lin J, et al.Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms[J].Expert Opin Drug Deliv, 2022, 19( 11 ): 1487-1504.
|
[6] |
Hao Z, Li X, Zhang R, et al.Stimuli-responsive hydrogels for antibacterial applications[J/OL].Adv Healthc Mater, 2024:e2400513.DOI:10.1002/adhm.202400513.
|
[7] |
Jahanbekam S, Mozafari N, Bagheri-Alamooti A, et al.Ultrasoundresponsive hyaluronic acid hydrogel of hydrocortisone to treat osteoarthritis[J/OL].Int J Biol Macromol, 2023, 240: 124449.DOI:10.1016/j.ijbiomac.2023.124449.
|
[8] |
Zhang C, Jiang G, Gao X.Matrix metalloproteinase-responsive drug delivery systems[J].BioconjugChem, 2023, 34( 8 ): 1349-1365.
|
[9] |
Chang M.Matrix metalloproteinase profiling and their roles in disease[J].RSC Adv, 2023, 13( 9 ): 6304-6316.
|
[10] |
Kim IS, Yang WS, Kim CH.Physiological properties, functions, and trends in the matrix metalloproteinase inhibitors in inflammationmediatedhuman diseases[J].Curr Med Chem, 2023, 30( 18 ):2075-2112.
|
[11] |
Itoh Y.Membrane-type matrix metalloproteinases: their functions and regulations[J].Matrix Biol, 2015, 44-46: 207-223.
|
[12] |
Kumar L, Nash A, Harms C, et al.Allosteric communications between domains modulate the activity of matrix metalloprotease-1[J].BiophysJ, 2020, 119( 2 ): 360-374.
|
[13] |
Roy HS, Murugesan P, Kulkarni C, et al.On-demand release of a selective MMP-13 blocker from an enzyme-responsive injectable hydrogel protects cartilage from degenerative progression in osteoarthritis[J].J Mater Chem B, 2024, 12( 22 ): 5325-5338.
|
[14] |
Li K, Tay FR, Yiu CKY.The past, present and future perspectives of matrix metalloproteinase inhibitors[J/OL].Pharmacol Ther,2020,207: 107465.DOI:10.1016/j.pharmthera.2019.107465.
|
[15] |
Stetler-Stevenson WG.The continuing Saga of tissue inhibitor of metalloproteinase 2 emerging roles in tissue homeostasis and cancer progression[J].Am J Pathol, 2023, 193( 10 ): 1336-1352.
|
[16] |
Kalev-Altman R, Janssen JN, Ben-Haim N, et al.The gelatinases,matrix metalloproteinases 2 and 9, play individual roles in skeleton developmen[tJ].Matrix Biol, 2022, 113: 100-121.
|
[17] |
Mukherjee A, Das B.The role of inflammatory mediators and matrix metalloproteinases( MMPs ) in the progression of osteoarthritis[J/OL].Biomater Biosyst,2024, 13: 100090.DOI:10.1016/j.bbiosy.2024.100090.
|
[18] |
Shih PC, Lee YH, Tsou HK, et al.Recent targets of osteoarthritis research[J/OL].Best PractResClinRheumatol,2023, 37( 2 ):101851.DOI:10.1016/j.berh.2023.101851.
|
[19] |
Danalache M, Umrath F, Riester R, et al.Proteolysis of the pericellular matrix: pinpointing the role and involvement of matrix metalloproteinases in early osteoarthritic remodeling[J].Acta Biomater, 2024, 181: 297-307.
|
[20] |
Mazur CM, Woo JJ, Yee CS, et al.Osteocyte dysfunction promotes osteoarthritis through MMP13-dependent suppression of subchondral bone homeostasis[J/OL].Bone Res, 2019, 7: 34.DOI:10.1038/s41413-019-0070-y.
|
[21] |
Lepetsos P, Papavassiliou KA, Papavassiliou AG.Redox and NF-κB signaling in osteoarthriti[sJ].Free Radic Biol Med,2019, 132: 90-100.
|
[22] |
Xiao SQ, Cheng M, Wang L, et al.The role of apoptosis in the pathogenesis of osteoarthritis[J].IntOrthop, 2023, 47( 8 ): 1895-1919.
|
[23] |
Sengprasert P, Waitayangkoon P, Kamenkit O, et al.Catabolic mediators from TLR2-mediated proteoglycan aggrecan peptidestimulated chondrocytes are reduced by Lactobacillus-conditioned media[J/OL].Sci Rep, 2024, 14( 1 ): 18043.DOI:10.1038/s41598-024-68404-9.
|
[24] |
Hu Y, Chen X, Wang S, et al.Subchondral bone microenvironment in osteoarthritis and pain[J/OL].Bone Res, 2021, 9( 1 ): 20.DOI:10.1038/s41413-021-00147-z.
|
[25] |
Zhao T, Deng H, Li J, et al.A smart MMP13-responsive injectable hydrogel with inflammatory diagnostic logic and multiphase therapeutic ability to orchestrate cartilage regeneration[J/OL].Adv Funct Materials, 2023, 33( 16 ): 2213019 DOI:10.1002/adfm.202213019.
|
[26] |
Zhou T, Xiong H, Yao SY, et al.Hypoxia and matrix metalloproteinase 13-responsive hydrogel microspheres alleviate osteoarthritis progression in vivo[J/OL].Small, 2024, 20( 19 ):e2308599.DOI:10.1002/smll.202308599.
|
[27] |
Gezer HH, Ostor A.What is new in pharmacological treatment for osteoarthritis?[J/OL].Best Pract Res Clin Rheumatol, 2023, 37( 2 ):101841.DOI:10.1016/j.berh.2023.101841.
|
[28] |
Xiang H, Zhang C, Xiong Y, et al.MMP13-responsive hydrogel microspheres for osteoarthritis treatment by precise delivery of celecoxib[J/OL].Mater Des, 2024, 241: 112966.DOI:10.1016/j.matdes.2024.112966.
|
[29] |
Miao K, Zhou Y, He X, et al.Microenvironment-responsive bilayer hydrogel microspheres with gelatin-shell for osteoarthritis treatmen[tJ/OL].Int J Biol Macromol, 2024, 261( pt2 ): 129862.DOI:10.1016/j.ijbiomac.2024.129862.
|
[30] |
Yi X, Xu Z, Liu Q, et al.Matrix metalloproteinase-responsive collagen-oxidized hyaluronic acid injectable hydrogels for osteoarthritic therapy[J/OL].Biomater Adv, 2022, 137: 212804.DOI:10.1016/j.bioadv.2022.212804.
|
[31] |
Zhang Y, Chen J, Sun Y, et al.Endogenous tissue engineering for chondral and osteochondral regeneration: strategies and mechanisms[J].ACS Biomater Sci Eng, 2024, 10( 8 ): 4716-4739.
|
[32] |
Li S, Zheng W, Deng W, et al.Logic-based strategy for spatiotemporal release of dual extracellular vesicles in osteoarthritis treatmen[tJ/OL].Adv Sci, 2024, 11( 26 ): e2403227.DOI:10.1002/advs.202403227.
|
[33] |
Park EH, Fritz J.The role of imaging in osteoarthritis[J/OL].Best Pract Res Clin Rheumatol, 2023, 37( 2 ): 101866.DOI:10.1016/j.berh.2023.101866.
|
[34] |
Lan Q, Lu R, Chen H, et al.MMP-13 enzyme and pH responsive theranosticnanoplatform for osteoarthritis[J/OL].J Nanobiotechnology, 2020, 18( 1 ): 117.DOI:10.1186/s12951-020-00666-7.
|
[35] |
Chen H, Qin Z, Zhao J, et al.Cartilage-targeting and dual MMP-13/pH responsive theranosticnanoprobes for osteoarthritis imaging and precision therapy[J/OL].Biomaterials, 2019, 225: 119520.DOI:10.1016/j.biomaterials.2019.119520.
|
[36] |
Zhou D, Wei Y, Sheng S, et al.MMP13-targeted siRNAloaded micelles for diagnosis and treatment of posttraumatic osteoarthritis[J].Bioact Mater, 2024, 37: 378-392.
|
[37] |
Brown S, Kumar S, Sharma B.Intra-articular targeting of nanomaterials for the treatment of osteoarthritis[J].Acta Biomater,2019, 93: 239-257.
|
[38] |
He L, Fan D, Liang W, et al.Matrix metalloproteinase-responsive PEGylated lipid nanoparticles for controlled drug delivery in the treatment of rheumatoid arthritis[J].ACS Appl Bio Mater, 2020, 3( 5 ): 3276-3284.
|
[39] |
He L, Qin X, Fan D, et al.Dual-stimuli responsive polymeric micelles for the effective treatment of rheumatoid arthritis[J].ACS Appl Mater Interfaces, 2021, 13( 18 ): 21076-21086.
|
[40] |
Lu Y, Chen J, Li L, et al.Hierarchical functional nanoparticles boost osteoarthritis therapy by utilizing joint-resident mesenchymal stem cells[J/OL].JNanobiotechnology, 2022, 20( 1 ): 89.DOI:10.1186/s12951-022-01297-w.
|
[41] |
Luan Z, Ma X, Zhao Q, et al.“Integrated diagnosis and treatment”of upconversion nanocomposite hydrogel for osteoarthritis treatmen[tJ/OL].Chem Eng J, 2024, 488: 150611.DOI:10.1016/j.cej.2024.150611.
|
[42] |
Li B, Wang F, Hu F, et al.Injectable “nano-micron” combined gene-hydrogel microspheres for local treatment of osteoarthritis[J/OL].NPG Asia Mater, 2022, 14: 1.DOI:10.1038/s41427-021-00351-7.
|